Ziyad, S., Jordahl, K., Hu, H., Thompson, E., Bal, S., Htut, M., Anderson, L., Gregory, T., Costa, L., Nadeem, O., Sarkis, N., Guo, Z., Kao, W., Kaeding, A., Kaiser, S., Burgess, M., Berdeja, J. (2025). Assessment of pharmacodynamic efficacy biomarkers from A phase 1, first-in-human study of arlocabtagene autoleucel (arlo-cel) in relapsed and refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-2223